News

Participation at the event is provided free of charge but pre-registration is expected (Registration).

The content will be also made available on demand later for those wo are registered yet are unable to attend.


The following program is scheduled:

15.00-15.05 Opening remarks (Gábor Benkovics)

15.05-15.45 Cyclodextrins as therapeutics agents (Tamás Sohajda)

15.45-16.25 Synthesis of Sugammadex (SGM) and its halogenated precursor – All the secrets uncovered (Milo Malanga, Tamás Nemcsok)


16.25-16.30 Break


16.30-17.25 Moderated round-table discussion with academists and industrial experts

   Gábor Benkovics, CycloLab – R&D Director (moderator)
   Cristin Davidson, Support Of Accelerated Research for Niemann-Pick C (SOAR-NPC) – Project Manager
   José Manuel Garcia Fernandez, University of Sevilla – Professor
   Sharon Hrynkow, Cyclo Therapeutics – CSO and SVP for Medical Affairs
   Milo Malanga, CycloLab – Senior Research Chemist
   Matthew ‘Oki’ O’Connor, Underdog Pharmaceuticals – co-CEO and co-Founder
   Tamás Sohajda, CycloLab – CEO
   Antonio Vargas-Berenguel University of Almeria – Professor  


17.25-17.30 Closing (Gábor Benkovics)

BACK TO NEWS